DIO Antibodies

Santa Cruz Biotechnology features a diverse variety of DIO Antibodies for targeting deiodinase iodothyronine type II (DIO2) protein. DIO Antibodies are compatible with western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). DIO2 plays a critical role in thyroid hormone metabolism by converting the prohormone thyroxine (T4) into the active form, triiodothyronine (T3), which is essential for regulating metabolism, growth, and development. Understanding DIO2 function is crucial for elucidating the mechanisms underlying thyroid-related disorders and metabolic diseases. The study of DIO2 and its regulation can provide insights into therapeutic targets for conditions such as hypothyroidism and obesity. Research focused on DIO2 continues to reveal new connections between thyroid hormone signaling and various physiological processes. Investigating DIO2 expression patterns helps scientists better understand tissue-specific responses to thyroid hormones. Exploring DIO2 activity provides valuable information about metabolic regulation across different organ systems. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing our understanding of thyroid hormone biology and its impact on human health.